Probiotics for preterm infants - time to end all controversies
Related Experiment Video
Updated: Jan 30, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Gayatri Athalye-Jape1,2, Sanjay Patole1,2
1Neonatal Directorate, King Edward Memorial Hospital for Women, Perth, WA, Australia.
Insights
Probiotics significantly reduce mortality, necrotising enterocolitis (NEC), and late onset sepsis (LOS) in preterm infants. This cost-effective intervention offers substantial benefits for infant health and survival.
Area of Science:
- Neonatalogy
- Pediatric Gastroenterology
- Microbiome Research
Background:
- Preterm infants (<32 weeks) face high risks of mortality, necrotising enterocolitis (NEC), late onset sepsis (LOS), and feeding intolerance.
- Complications of NEC and LOS, including neurodevelopmental impairment (NDI), impose a significant health and economic burden.
- Feeding intolerance contributes to postnatal growth failure in extremely preterm infants.
Purpose of the Study:
- To evaluate the efficacy of probiotics in reducing mortality, NEC, LOS, and feeding intolerance in preterm infants.
- To address controversies hindering the widespread adoption of probiotics for preterm infant care.
- To highlight the cost-effectiveness and significant benefits of probiotic prophylaxis.
Main Methods:
- Systematic reviews and meta-analyses of randomized controlled trials (RCTs) involving approximately 12,000 preterm infants.
- Analysis of non-randomized controlled trials (non-RCTs) to confirm benefits in real-world settings.
- Assessment of the cost-effectiveness of probiotics as a standard prophylactic measure.
Main Results:
- Probiotics significantly reduce the risk of all-cause mortality, NEC (≥ Stage II), LOS, and feeding intolerance in preterm infants.
- Benefits observed in RCTs are corroborated by systematic reviews of non-RCTs.
- Probiotic prophylaxis is highly cost-effective, costing less than a dollar per day.
Conclusions:
- Probiotics are a highly effective and cost-effective intervention for improving outcomes in preterm infants.
- Widespread adoption of probiotics as standard prophylaxis is recommended to reduce mortality, NEC, LOS, and feeding intolerance.
- Further research and addressing current controversies can accelerate the uptake of this beneficial intervention.
Abstract:
Mortality, necrotising enterocolitis (NEC), late onset sepsis (LOS) and feeding intolerance are significant issues for very preterm (< 32 weeks) and extremely preterm (< 28 weeks) infants. The complications of ≥ Stage II NEC [e.g. Resection of the gangrenous gut, survival with intestinal failure, recurrent infections, prolonged hospital stay, and long-term neurodevelopmental impairment (NDI)] impose a significant health burden. LOS also carries significant burden including long-term NDI due to adverse effects of inflammation on the preterm brain during the critical phase of development. Frequent stopping of feeds due to feeding intolerance is a significant iatrogenic contributor to postnatal growth failure in extremely preterm infants. Over 25 systematic reviews and meta-analyses of RCTs (~12 000 participants) have reported that probiotics significantly reduce the risk of all-cause mortality, NEC ≥ Stage II, LOS and feeding intolerance in preterm infants. Systematic reviews and meta-analysis of non-RCTs have also shown that the benefits after adopting probiotics as a standard prophylaxis for preterm infants are similar to those reported in RCTs. No intervention comes close to probiotics when it comes to significant reduction in death, NEC, LOS and feeding intolerance at a cost of less than a dollar a day irrespective of the setting and baseline incidence of NEC. The common controversies that are preventing the rapid uptake of probiotics for preterm infants are addressed in this paper.
Related Concept Videos
Drug Dosing: Infants and Children
Mean free path and Mean free time
Mixing Time
Generation Time
Time Course of Drug Effect
Setting Time of Cement

